Short-Bio: Dimitrios Lamprou (Ph.D., MBA) is Full Professor (Chair) of Biofabrication and Advanced Manufacturing, and Director at MSc Industrial Pharmaceutics at Queen’s University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and the Chair of the Academy of Pharmaceutical Sciences (APS) Emerging Technologies Focus Group. Dimitrios, is the author of over 150 peer-reviewed publications, has over 350 conference abstracts, has given over 150 Invited Talks in institutions and conferences across the world, and has secure Funding more than £3M. Dimitrios has been recognised as world leader in 3D Printing & Microfluidics. PubMed-based algorithms placed him in the top 0.088% of scholars in the world writing about 3D Printing and on the top 0.071% of scholars in the world writing about microfluidics, in the past 10-years. Moreover, PubMed-based algorithms placed him in the top 0.63% of scholars writing about nanofibers. Dimitrios has also been named in the Stanford University’s list 2021 & 2022 of World’s Top 2% Scientists, for his research in Pharmaceutics and Biomedical Engineering. For more info, please visit www.
Bullet points of the presentation:
- 3D & 4D bioprinting in the manufacturing of microfluidic chips and drug delivery systems.
- The production of nanomedicines by microfluidics.
- Lab-on-a-chip applications.
- BioMEMS for diagnostics and drug-delivery.
- Sustainable and scalable formulation solutions.
Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_7lOYWYPQQrWq_FBUKDuMtw After registering, you will receive a confirmation email containing information about joining the webinar.